Amneal Pharmaceuticals, Inc. (AMRX) has a consensus analyst rating of Buy, based on 16 analysts covering the stock. Of those, 10 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for AMRX is $16.00, representing a +22.0% upside from the current price of $13.12. Price targets range from a low of $15.00 to a high of $17.00.
